TET-AAV-E2F4DN

N/A

Report date: 2025/03/28 15:24:00

Base Information

Drug NameTET-AAV-E2F4DN
Drug Alias NameTETRANEURON AAV-E2F4DNAAV-E2F4DNE2F4DN ALZHEIMER
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionTranscription factor E2F4 gene transference
TargetsTranscription factor E2F4
Therapy Area/IndicationsGlaucomaAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetraneuron SL
China Registration ClassN/A

Develop Information

Active CompaniesTetraneuron SL
Inactive CompaniesN/A
Active IndicationsGlaucomaAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A